Edwards Lifesciences Corp Earnings Dividend

Edwards Lifesciences Corp’s revenue jumped 13.63% since last year same period to $1741Mn in the Q2 2026. On a quarterly growth basis, Edwards Lifesciences Corp has generated 5.6% jump in its revenue since last 3-months.

Edwards Lifesciences Corp’s net profit fell -26.65% since last year same period to $241.9Mn in the Q2 2026. On a quarterly growth basis, Edwards Lifesciences Corp has generated -36.46% fall in its net profits since last 3-months.

Edwards Lifesciences Corp’s net profit margin fell -35.45% since last year same period to 13.89% in the Q2 2026. On a quarterly growth basis, Edwards Lifesciences Corp has generated -39.83% fall in its net profit margins since last 3-months.

Edwards Lifesciences Corp’s earning per share (EPS) estimates for the current quarter stand at 0.74 - a 1.37% jump from last quarter’s estimates.

Edwards Lifesciences Corp’s earning per share (EPS) estimates for the current year stand at 0.74.

Edwards Lifesciences Corp’s earning per share (EPS) jumped 16.42% since last year same period to 0.78 in the Q2 2026. This indicates that the Edwards Lifesciences Corp has generated 16.42% annual rate of jump in its earning per share (EPS) in the last 4 quarters.